These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30785092)

  • 1. Rituximab as an effective and probably safe treatment for granulomatosis with polyangiitis (Wegener's Granulomatosis).
    Tavakolpour S; Alesaeidi S
    Int Immunopharmacol; 2019 May; 70():67-68. PubMed ID: 30785092
    [No Abstract]   [Full Text] [Related]  

  • 2. Two cases of refractory Wegener's granulomatosis successfully treated with rituximab.
    Tamura N; Matsudaira R; Hirashima M; Ikeda M; Tajima M; Nawata M; Morimoto S; Kaneda K; Kobayashi S; Hashimoto H; Takasaki Y
    Intern Med; 2007; 46(7):409-14. PubMed ID: 17409608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis.
    Bachmeyer C; Cadranel JF; Demontis R
    Nephrol Dial Transplant; 2005 Jun; 20(6):1274. PubMed ID: 15840659
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pulsed doses of cyclophosphamide in the treatment of Wegener's granulomatosis].
    Kovacević Z; Mitrović D; Tomić I; Jovanović D; Skatarić V; Dimitrijević J; Rabrenović V; Trifunović G
    Vojnosanit Pregl; 1999; 56(1):31-7. PubMed ID: 10230331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
    Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
    Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
    Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
    Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
    [No Abstract]   [Full Text] [Related]  

  • 9. Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.
    Lynch JP; Derhovanessian A; Tazelaar H; Belperio JA
    Semin Respir Crit Care Med; 2018 Aug; 39(4):434-458. PubMed ID: 30404111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse cyclophosphamide therapy for Wegener's granulomatosis.
    Cowdery JS
    Am J Med; 1991 Sep; 91(3):321-2. PubMed ID: 1892157
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab Induction and Maintenance Treatment in Patients with Scleritis and Granulomatosis with Polyangiitis (Wegener's).
    You C; Ma L; Lasave AF; Foster CS
    Ocul Immunol Inflamm; 2018; 26(8):1166-1173. PubMed ID: 28628344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab.
    Geetha D; Kallenberg C; Stone JH; Salama AD; Appel GB; Duna G; Brunetta P; Jayne D
    J Nephrol; 2015 Feb; 28(1):17-27. PubMed ID: 25185728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in refractory Wegener's granulomatosis: Favorable or not?
    Aries PM; Lamprecht P; Gross WL
    Am J Respir Crit Care Med; 2006 Apr; 173(7):815-6; author reply 816. PubMed ID: 16556703
    [No Abstract]   [Full Text] [Related]  

  • 14. Macular oedema following rituximab infusion in two patients with Wegener's granulomatosis.
    Bussone G; Kaswin G; de Menthon M; Delair E; Brézin AP; Guillevin L
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):90-2. PubMed ID: 20412711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis.
    Huchzermeyer C; Mardin C; Holbach L; Zwerina J; Schett G; Rech J
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S97-101. PubMed ID: 20862503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
    Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
    Azar L; Springer J; Langford CA; Hoffman GS
    Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis.
    Lê Thi Huong D; Papo T; Piette JC; Wechsler B; Blétry O; Lamas G; Baumelou A; Le Hoang P; Pennaforte JL; Valcke JC; Godeau P
    Clin Exp Rheumatol; 1996; 14(1):9-16. PubMed ID: 8697666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.
    Tektonidou MG; Skopouli FN
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S103. PubMed ID: 16859607
    [No Abstract]   [Full Text] [Related]  

  • 20. L25. Medical treatment of subglottic stenosis in granulomatosis with polyangiitis (Wegener's).
    Monach PA
    Presse Med; 2013 Apr; 42(4 Pt 2):575-6. PubMed ID: 23453209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.